G.3.2 is a novel allele of the gene connector enhancer of ksr ( cnk ) in Drosophila melanogaster .

Autor: Chammout H; University of Detroit Mercy, Detroit, Michigan, United States., Adkins DL; Ohio Northern University, Ada, Ohio, United States., Al-Olimat AK; Ohio Northern University, Ada, Ohio, United States., Alsaad Z; University of Detroit Mercy, Detroit, Michigan, United States., Altopp BM; Clark University, Worcester, Massachusetts, United States., Amer T; Clark University, Worcester, Massachusetts, United States., Apampa FO; Clark University, Worcester, Massachusetts, United States., Avery GR; Ohio Northern University, Ada, Ohio, United States., Bazzi II; University of Detroit Mercy, Detroit, Michigan, United States., Beck ED; Ohio Northern University, Ada, Ohio, United States., Beier EL; Clark University, Worcester, Massachusetts, United States., Belisle BS; Clark University, Worcester, Massachusetts, United States., Benton L; Ohio Northern University, Ada, Ohio, United States., Bolyard MM; Ohio Northern University, Ada, Ohio, United States., Brain OE; Ohio Northern University, Ada, Ohio, United States., Buckner ET; Ohio Northern University, Ada, Ohio, United States., Chowdhury SR; University of Detroit Mercy, Detroit, Michigan, United States., Cifranic JR; Ohio Northern University, Ada, Ohio, United States., Cleary L; Clark University, Worcester, Massachusetts, United States., Clum TR; Ohio Northern University, Ada, Ohio, United States., Cruz AM; Ohio Northern University, Ada, Ohio, United States., DeGray MV; Clark University, Worcester, Massachusetts, United States., Echeverry IL; Clark University, Worcester, Massachusetts, United States., El Dana H; University of Detroit Mercy, Detroit, Michigan, United States., Elkadri SK; University of Detroit Mercy, Detroit, Michigan, United States., Estep PL; Ohio Northern University, Ada, Ohio, United States., Falke LR; Ohio Northern University, Ada, Ohio, United States., Foor HJ; Ohio Northern University, Ada, Ohio, United States., Gullapalli AS; University of Detroit Mercy, Detroit, Michigan, United States., Hakim SS; University of Detroit Mercy, Detroit, Michigan, United States., Hazime HB; University of Detroit Mercy, Detroit, Michigan, United States., Heininger LE; Ohio Northern University, Ada, Ohio, United States., Hoeft EG; Ohio Northern University, Ada, Ohio, United States., James LM; Ohio Northern University, Ada, Ohio, United States., Jeon Y; University of Detroit Mercy, Detroit, Michigan, United States., Johnson MR; Ohio Northern University, Ada, Ohio, United States., Jordan LP; Ohio Northern University, Ada, Ohio, United States., Khan Z; University of Detroit Mercy, Detroit, Michigan, United States., Kochensparger SK; Clark University, Worcester, Massachusetts, United States., Koria FJ; University of Detroit Mercy, Detroit, Michigan, United States., Krasnow RM; Clark University, Worcester, Massachusetts, United States., Lilly V; Ohio Northern University, Ada, Ohio, United States., Lim E; Clark University, Worcester, Massachusetts, United States., MacCormack IT; Clark University, Worcester, Massachusetts, United States., Malesh A; Clark University, Worcester, Massachusetts, United States., Mariano MG; Ohio Northern University, Ada, Ohio, United States., Mentzer AC; Ohio Northern University, Ada, Ohio, United States., Messner KH; Ohio Northern University, Ada, Ohio, United States., Myers KC; Ohio Northern University, Ada, Ohio, United States., Newman ER; Clark University, Worcester, Massachusetts, United States., Richters AM; Ohio Northern University, Ada, Ohio, United States., Romero L; University of Detroit Mercy, Detroit, Michigan, United States., Rotem A; Clark University, Worcester, Massachusetts, United States., Saho RJ; Ohio Northern University, Ada, Ohio, United States., Sawaki K; Ohio Northern University, Ada, Ohio, United States., Selders AN; Ohio Northern University, Ada, Ohio, United States., Shockney E; Ohio Northern University, Ada, Ohio, United States., Sobh FA; University of Detroit Mercy, Detroit, Michigan, United States., Speiser IF; Clark University, Worcester, Massachusetts, United States., Sproul BM; Ohio Northern University, Ada, Ohio, United States., Sroufe VJ; Ohio Northern University, Ada, Ohio, United States., Tollkuci A; Clark University, Worcester, Massachusetts, United States., Trevino CC; Clark University, Worcester, Massachusetts, United States., Vapenik MA; Ohio Northern University, Ada, Ohio, United States., Wagner EM; Ohio Northern University, Ada, Ohio, United States., Bieser KL; Nevada State University, Henderson, Nevada, United States., Siders JL; Ohio Northern University, Ada, Ohio, United States., Thackeray JR; Clark University, Worcester, Massachusetts, United States., Kagey JD; University of Detroit Mercy, Detroit, Michigan, United States.

Publikováno v: MicroPublication biology [MicroPubl Biol] 2024 Sep 26; Vol. 2024. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).

Citrobacter braakii CLABSI in a hematopoietic stem cell transplant patient

Autor: Rebecca Myers, Eris Tollkuci

Publikováno v: Journal of Oncology Pharmacy Practice. 27:1792-1794

Introduction Citrobacter bacteria are gram-negative anaerobic bacilli commonly found in water, soil, food, and the intestinal tracts of animals and humans. Patients at highest risk of these nosocomial infections include neonates and adults who are �

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2dffe5db207d0e1d163cebc13ab32e45
https://doi.org/10.1177/10781552211001423

Gilteritinib administration in a hemodialysis patient

Autor: Rebecca Myers, Eris Tollkuci, Tiffany Tran

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(5)

Introduction Gilteritinib is a multitargeted tyrosine kinase inhibitor (TKI) approved by the Food and Drug Administration (FDA) for acute myeloid leukemia (AML) with a FMS-related tyrosine kinase 3 (FLT3) mutation. The pharmacokinetics of gilteritini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd5393c0d3502251cd79e77cb107ff0
https://pubmed.ncbi.nlm.nih.gov/33175659

Midostaurin administration in two hemodialysis patients

Autor: Musa Mulseh, Amanda N. Seddon, Laura Geswein, Eris Tollkuci

Publikováno v: Journal of Oncology Pharmacy Practice. 25:1285-1288

Midostaurin is a multitargeted tyrosine kinase inhibitor approved by the Food and Drug Administration for FMS-related tyrosine kinase 3-positive acute myeloid leukemia in combination with standard daunorubicin and cytarabine induction and high-dose c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3da43aed1a5e1d90ea496ab5d096fde
https://doi.org/10.1177/1078155218801067

Letermovir Prophylaxis Outcomes in Allogeneic Hematopoietic Cell Transplant Recipients

Autor: Hyun Don Yun, Mohammad Junaid Hussain, Gizem Yassa, Ankur Varma, Celalettin Ustun, Jacqueline Baptista, Becca Myers, Sunita Nathan, Sarah Ziny, Kathryn A McDonnell, Eris Tollkuci, Anu Kadanagowd, Mogboluwaga Oginni, Debra A. Marinovic

Publikováno v: Transplantation and Cellular Therapy. 27:S367-S368

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9cf3838535a2be6f91eaac81f45c9024
https://doi.org/10.1016/s2666-6367(21)00472-3